Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008

NCT04770194 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome
Stroke

Interventions

DRUG: SP-8008 Prototype Capsule A
DRUG: SP-8008 Prototype Capsule B
DRUG: Placebo

Sponsor

Shin Poong Pharmaceutical Co. Ltd.